Sep 17, 2021

Featuring perspectives from Dr Krishnansu S Tewari and Ms Courtney Arn, including the following topics:

• Role of PARP Inhibitors in the Management of Ovarian Cancer
  • Introduction (0:00)
  • Case: A woman in her early 50s with Stage IIIC ovarian cancer and a germline BRCA1 mutation — Courtney Arn, CNP (15:09)
  • Case: A woman in her early 70s with Stage IIIC HRD-positive ovarian cancer — Ms Arn (22:05)
• Immunotherapy for Endometrial Cancer
  • Case: A woman in her early 80s with recurrent endometrial cancer, MMR proficient — Ms Arn (29:56)
  • Case: A woman in her mid-50s with recurrent endometrial cancer, MSI-high — Ms Arn (39:36)
• Treatment of Relapsed Cervical Cancer
  • Case: A woman in her late 50s with recurrent cervical cancer, PD-L1-positive — Ms Arn (41:50)
  • Case: A woman in her late 30s with recurrent cervical cancer, PD-L1-negative — Ms Arn (52:07)

NCPD information and select publications